SRUK continues to fund and support essential scientific and medical research that aims to make life better for everyone living with scleroderma and Raynaud's.

Our vision is to develop new, effective treatments and ultimately find a cure. Research is crucial to everything that we do, and enables us to look at every aspect of what may cause, affect and treat these conditions; including which drugs and therapies will have the biggest impact. The benefits of medical research are far-reaching and ultimately it helps everyone; from the thousands of people and families in the UK who are affected by scleroderma and Raynaud's, to the health professionals who are involved in the management of these complex conditions.

SRUK was founded in 2016 and we are proud of the legacy of our two founding charities: the Raynaud's and Scleroderma Association (RSA) and the Scleroderma Society. Our impact report celebrates the impact of over 3 decades of research. Your support has funded over 100 research grants, and over £10 million in cutting edge science. You can read about the advances that have been made at all levels, from building our knowledge about the very basic mechanisms underlying the conditions through to pioneering new methods of earlier detection and diagnosis. This has set us up for the future and we are now in the incredible position of being able to accelerate research even further than it has been before. This is all due to the groundbreaking work that has been carried out through our communities working together. Click to see the Impact Report.

Get involved in research

Could you be a part of the next phase of scientific research into scleroderma or Raynaud's? Please follow the links below to find out more, including all the latest research news as well as the various ways you could get involved in an upcoming project. If you would like any more information, please get in touch with us, as we will be very happy to help.